Stocktoria

Autolus Therapeutics plc AUTL

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-22 · LEI

Autolus Therapeutics plc institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.4,436,102$15.4M1.67%
RENAISSANCE TECHNOLOGIES LLC2,299,499$3.2M0.86%
CITADEL ADVISORS LLC585,804$808,4100.22%
Point72 Asset Management, L.P.426,983$589,2370.16%
MILLENNIUM MANAGEMENT LLC204,728$282,5250.08%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.